Iveco Group (MI: IVG) is a global automotive leader active in the Commercial & Specialty Vehicles, Powertrain, and related Financial Services arenas. Each of its eight brands is a major force in its specific business: IVECO, a pioneering commercial vehicles brand that designs, manufactures, and markets heavy, medium, and light-duty trucks; FPT Industrial, a global leader in a vast array of advanced powertrain technologies in the agriculture, construction, marine, power generation, and commercial vehicles sectors; IVECO BUS and HEULIEZ, mass-transit and premium bus and coach brands; IDV, for highly-specialised defence and civil protection equipment; ASTRA, a leader in large-scale heavy-duty quarry and construction vehicles; Magirus, the industry-reputed firefighting vehicle and equipment manufacturer; and IVECO CAPITAL, the financing arm which supports them all. Iveco Group employs approximately 34,000 people around the world and has 28 manufacturing plants and 29 R&D centres.

​

WIN is pleased to welcome IVECO as a leading sponsor of the 2022 Global WINConference, and grateful to work together on this important mission for a more sustainable, conscious and feminine future.

​

​

Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. We have a high bar for innovation focused on disease areas with significant unmet need where our medicines can truly make a difference for patients. Through the Bristol Myers Squibb Foundation, an independent 501(c)(3) charitable organization, we support community-based programs that promote cancer awareness, screening, care and support among high-risk populations in the United States, as well as China, Brazil and sub-Saharan Africa. Our employees around the world work every day to transform patients’ lives through science. Celgene and Juno Therapeutics are wholly owned subsidiaries of Bristol Myers Squibb company. In certain countries outside the U.S., due to local laws, Celgene and Juno Therapeutics are referred to as, Celgene, a Bristol Myers Squibb company and Juno Therapeutics, a Bristol Myers Squibb company.

​

“The Bristol Myers Squibb Network of Women (B-NOW) is proud to sponsor the 2021 WIN Global Conference. The high quality content mix of global trends, future ways of working, leading as women and personal career development provides an inspiring, thought provoking and unique experience.”

​

​

The purpose-led, performance-driven company. Royal DSM is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. DSM’s purpose is to create brighter lives for all. DSM’s products and solutions address some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders - customers, employees, shareholders, and society at large. 

​

“In order to deliver our strategy, we need more diversity at DSM—including more women in positions of leadership. DSM sponsors the WIN event because we believe that fostering further development of our talents makes business sense. Providing DSM employees with opportunities to participate in the unique, global, and thought-provoking event that is WIN, reaps benefits for everyone, including new energy, ideas and connections.”

​

​

Pernod Ricard EMEA & LATAM spans over 3 continents and more than 55 markets and is one of the 4 regional entities of Pernod Ricard, the world’s No 2 in wines and spirits. The Group’s mission is to unlock the magic of human connections by bringing “Good Times from a Good Place”, in line with its Sustainability and Responsibility roadmap. Pernod Ricard’s decentralised organisation empowers its 19,480 employees to be on-the-ground ambassadors of its purposeful and inclusive culture of conviviality, bringing people together in meaningful, sustainable and responsible ways to create value over the long term. Executing its strategic plan, Transform & Accelerate, Pernod Ricard now relies on its “Conviviality Platform”, a new growth model based on data and artificial intelligence to meet the ever-changing demand of consumers.  

​

"At Pernod Ricard, « Convivialité » is our purpose and at the core of our business. Our ambition is to transform any social interaction into a moment of authentic, sincere and responsible sharing. We are delighted to partner with WIN as we believe when we collectively contribute to a more inclusive world, free from bias, we inspire ourselves, women and men, to create a better future together.

​

Medela was founded in 1961 in Baar, Switzerland. With more than 1500 employees worldwide we are serving more than 14 million patients, moms and babies every year. Through advancing research, observing natural behavior and listening to our customers, we turn science into care, nurturing health for generations.

​

“Medela is dedicated to supporting mothers and women to thrive in their personal and professional lives. The partnership with WIN aligns with our commitment to an inclusive culture that fosters equality, diversity, personal growth and well-being.”